Cited by 1,149Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolismTrace Elements in Health

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., Marsden, C. D.·1989·Journal of Neurochemistry

DOI 10.1111/j.1471-4159.1989.tb07264.x

Open this paper in CoChat — free account

Abstract

Levels of iron, copper, zinc, manganese, and lead were measured by inductively coupled plasma spectroscopy in parkinsonian and age-matched control brain tissue. There was 31-35% increase in the total iron content of the parkinsonian substantia nigra when compared to control tissue. In contrast, in the globus pallidus total iron levels were decreased by 29% in Parkinson's disease. There was no change in the total iron levels in any other region of the parkinsonian brain. Total copper levels were reduced by 34-45% in the substantia nigra in Parkinson's disease; no difference was found in the other brain areas examined. Zinc levels were increased in substantia nigra in Parkinson's disease by 50-54%, and the zinc content of the caudate nucleus and lateral putamen was also raised by 18-35%. Levels of manganese and lead were unchanged in all areas of the parkinsonian brain studied when compared to control brains, except for a small decrease (20%) in manganese content of the medial putamen. Increased levels of total iron in the substantia nigra may cause the excessive formation of toxic oxygen radicals, leading to dopamine cell death.

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.1989.tb07264.x

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
The effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397
Self-citation
Chronic parkinsonism secondary to intravenous injection of meperidine analogues
Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., & Kopin, I. J. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90006-4 · Cited by 1,377
FERRITIN: STRUCTURE, GENE REGULATION, AND CELLULAR FUNCTION IN ANIMALS, PLANTS, AND MICROORGANISMS
Theil, E. C. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.001445 · Cited by 1,337
Increased nigral iron content in postmortem parkinsonian brain
Dexter, D. T., Wells, F. R., Agid, F., Agid, Y., Lees, A. J., Jenner, P., & Marsden, C. D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91361-4 · Cited by 963
Self-citation
Autoxidation versus Covalent Binding of Quinones as the Mechanism of Toxicity of Dopamine, 6-Hydroxydopamine, and Related Compounds toward C1300 Neuroblastoma Cells in Vitro
Graham, D. G., Tiffany, S. M., BELL, W. R., & Gutknecht, W. F. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13536-0 · Cited by 953
The importance of free radicals and catalytic metal ions in human diseases.
Halliwell, B., & Gutteridge, J. M. C. (1985) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(85)90001-9 · Cited by 941
Iron-Responsive Elements: Regulatory RNA Sequences That Control mRNA Levels and Translation
Casey, J. L., Hentze, M. W., Koeller, D. M., Caughman, S. W., Rouault, T. A., Klausner, R. D., & Harford, J. B. (1988) · Science · doi:10.1126/science.2452485 · Cited by 709
Brain Peroxidase and Catalase in Parkinson Disease
Ambani, L. M., Woert, M. H. V., & Murphy, S. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490440064010 · Cited by 404

Show all 29 references

Research works printed but not linked: 4

Barbeau A., 1985, Uneven prevalence of Parkinson's disease in the province of Quebec, Can. J. Neurol. Sci., 12, 169
Barbeau A., 1986, Advances in Neurology, 299
Donaldson J., 1974, Advances in Neurology, 245
Youdim M. B. H., 1985, Handbook of Neurochemisiry, 731

Sorted by citations

Items 601–700 of 1,000

Effects of squalene/squalane on dopamine levels, antioxidant enzyme activity, and fatty acid composition in the striatum of Parkinson^|^rsquo;s disease mouse model
Kabuto, H., Yamanushi, T. T., Janjua, N. A., Takayama, F., & Mankura, M. (2013) · Journal of Oleo Science · doi:10.5650/jos.62.21 · Cited by 33
Mitochondrial respiratory enzyme function and superoxide dismutase activity following brain glutathione depletion in the rat
Seaton, T. A., Jenner, P. G., & MARSDEN, C. D. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00452-2 · Cited by 33
Self-citation
Prevention by Ginkgo biloba extract (EGb 761) and trolox C of the decrease in synaptosomal dopamine or serotonin uptake following incubation
Ramassamy, C., Naudin, B., Christen, Y., Clostre, F., & Costentin, J. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90685-c · Cited by 33
Quantitative estimation of regional brain iron with magnetic resonance imaging
Martin, W. R. W. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70818-1 · Cited by 32
Oxidative stress in zinc-induced dopaminergic neurodegeneration: Implications of superoxide dismutase and heme oxygenase-1
Singh, B. K., Kumar, A., Ahmad, I., Kumar, V., Patel, D. K., Jain, S. K., & Singh, C. (2011) · Free Radical Research · doi:10.3109/10715762.2011.607164 · Cited by 32
Imaging of neuronal tissues by x-ray diffraction and x-ray fluorescence microscopy: evaluation of contrast and biomarkers for neurodegenerative diseases
Carboni, E., Nicolas, J., Töpperwien, M., Stadelmann, C., Lingor, P., & Salditt, T. (2017) · Biomedical Optics Express · doi:10.1364/boe.8.004331 · Cited by 32
Selenium speciation analysis in the cerebrospinal fluid of patients with Parkinson’s disease
Maass, F., Michalke, B., Willkommen, D., Schulte, C., Tönges, L., Boerger, M., Zerr, I., Bähr, M., & Lingor, P. (2019) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2019.126412 · Cited by 32
Zinc antagonizes iron-regulation of tyrosine hydroxylase activity and dopamine production in Drosophila melanogaster
Xiao, G., Zhao, M., Liu, Z., Du, F., & Zhou, B. (2021) · BMC Biology · doi:10.1186/s12915-021-01168-0 · Cited by 33
Shikonin Protects Dopaminergic Cell Line PC12 Against 6-Hydroxydopamine-Mediated Neurotoxicity Via Both Glutathione-Dependent and Independent Pathways and by Inhibiting Apoptosis
Esmaeilzadeh, E., Gardaneh, M., Gharib, E., & Sabouni, F. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1061-9 · Cited by 32
17β-Estradiol reduces nitrotyrosine immunoreactivity and increases SOD1 and SOD2 immunoreactivity in nigral neurons in male mice following MPTP insult
Tripanichkul, W., Sripanichkulchai, K., Duce, J. A., & Finkelstein, D. I. (2007) · Brain Research · doi:10.1016/j.brainres.2007.05.076 · Cited by 32
Calpain Upregulation in Spinal Cords of Mice with 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced Parkinson's Disease
Ray, S. K., Wilford, G. G., Ali, S. F., & Banik, N. L. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05202.x · Cited by 32
6-Hydroxydopamine-lesioning of the nigrostriatal pathway in rats alters basal ganglia mRNA for copper, zinc- and manganese-superoxide dismutase, but not glutathione peroxidase
Kunikowska, G., & Jenner, P. G. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03149-3 · Cited by 32
Self-citation
Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6‐hydroxydopamine
Barkats, M., Millecamps, S., Bilang‐Bleuel, A., & Mallet, J. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00952.x · Cited by 32
Enhancement of Dopaminergic Neurotoxicity by the Mercapturate of Dopamine
Zhang, J., Kravtsov, V., Amarnath, V., Picklo, M. J., Graham, D. G., & Montine, T. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740970.x · Cited by 32
Ganglioside-dependent factor, inhibiting lipid peroxidation in rat brain synaptosomes
Tyurin, V. A., Tyurina, Y. Y., & Avrova, N. F. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90055-v · Cited by 32
Effects of Atypical Antioxidative Agents,S‐nitrosoglutathione and Manganese, on Brain Lipid Peroxidation Induced by Iron Leaking from Tissue Disruption
Rauhala, P. V., & Chiueh, C. C. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06190.x · Cited by 32
Iron dyshomeostasis in Parkinson’s disease
Fuentes-Salazar, J. M., Mena, N. P., & Núñez, M. T. (2006) · Springer eBooks · doi:10.1007/978-3-211-33328-0_22 · Cited by 32
The Association of Iron and the Pathologies of Parkinson’s Diseases in MPTP/MPP+-Induced Neuronal Degeneration in Non-human Primates and in Cell Culture
Shi, L., Huang, C., Luo, Q., Rogers, E. A., Xia, Y., Liu, W., Ma, W., Zeng, W., Gong, L., Fang, J., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00215 · Cited by 31
The role of alpha-synuclein as ferrireductase in neurodegeneration associated with Parkinson’s disease
Sian‐Hülsmann, J., & Riederer, P. F. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02192-0 · Cited by 32
Alpha-synuclein aggregation is involved in the toxicity induced by ferric iron to SK-N-SH neuroblastoma cells
He, Q. W., Song, N., Xu, H., Wang, R., Xie, J., & Jiang, H. F. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0453-0 · Cited by 31
The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice
Youdim, M. B. H., Grünblatt, E., & Mandel, S. A. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0499-1 · Cited by 31
Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer’s disease
Bica, L., Crouch, P. J., Cappai, R., & White, A. R. (2008) · Molecular BioSystems · doi:10.1039/b816577g · Cited by 33
Defining a role for hemoglobin in Parkinson’s disease
Freed, J., & Chakrabarti, L. (2016) · npj Parkinson s Disease · doi:10.1038/npjparkd.2016.21 · Cited by 30
Alpha-synuclein ferrireductase activity is detectible in vivo, is altered in Parkinson's disease and increases the neurotoxicity of DOPAL
McDowall, J., Ntai, I., Honeychurch, K. C., Hart, J. P., Colin, P., Schneider, B. L., & Brown, D. R. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.08.001 · Cited by 36
Serum lipid peroxides in patients with Parkinson's disease
Molina, J., Jiménez‐Jiménez, F. J., Fernández–Calle, P., Lalinde, L., Tenías, J. M., Pondal, M., Vázquez, A., & Codoceo, R. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90033-4 · Cited by 31
Modulation of Iron Regulatory Protein-1 by Various Metals
Oshiro, S., Nozawa, K., Hori, M., Zhang, C., Hashimoto, Y., Kitajima, S., & Kawamura, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6182 · Cited by 31
Deprenyl's effect at slowing progression of parkinsonian disability: the DATATOP study
LeWitt, P. A. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb05025.x · Cited by 31
Modulation by neurosteroids of the in vivo (+)-[3H]SKF-10,047 binding to ?1 receptors in the mouse forebrain
Maurice, T., Roman, F. J., & Privat, A. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19961215)46:6 · Cited by 100
Superoxide Dismutase Expression in Parkinson's Disease
Poirier, J., Dea, D., Baccichet, A., & THIFFAUL, C. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21796.x · Cited by 31
Characterization of anomalous relaxation using the time-fractional Bloch equation and multiple echo T2*-weighted magnetic resonance imaging at 7 T
Qin, S., Liu, F., Turner, I., Yu, Q., Yang, Q., & Vegh, V. (2016) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26222 · Cited by 30
Is Chelation Therapy a Potential Treatment for Parkinson’s Disease?
Ward, R. J., Dexter, D. T., Martín‐Bastida, A., & Crichton, R. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073338 · Cited by 30
Self-citation
Parkinson’s disease therapy: what lies ahead?
Wolff, A. W., Schumacher, N. U., Pürner, D., Machetanz, G., Demleitner, A. F., Feneberg, E., Hagemeier, M., & Lingor, P. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02641-6 · Cited by 36
Detection of neuronal loss using T1ρ MRI assessment of 1H2O spin dynamics in the aphakia mouse
Michaeli, S., Burns, T. C., Kudishevich, E., Harel, N., Hanson, T., Sorce, D. J., Garwood, M., & Low, W. C. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.10.025 · Cited by 30
Longitudinal Associations of Magnetic Susceptibility with Clinical Severity in Parkinson's Disease
Thomas, G. E. C., Hannaway, N., Zarkali, A., Shmueli, K., & Weil, R. S. (2024) · Movement Disorders · doi:10.1002/mds.29702 · Cited by 29
Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients
Fernández, B., Ferrer, I., Gil, F., & Hilfiker, S. (2017) · Toxicology Reports · doi:10.1016/j.toxrep.2017.03.005 · Cited by 29
An electrospray/inductively coupled plasma dual-source time-of-flight mass spectrometer for rapid metallomic and speciation analysis: instrument design
Rogers, D. A., Ray, S. J., & Hieftje, G. M. (2008) · Metallomics · doi:10.1039/b816732j · Cited by 29
Impairment of dynamic thiol–disulphide homeostasis in patients with idiopathic Parkinson’s disease and its relationship with clinical stage of disease
Vural, G., Gümüşyayla, Ş., Bektaş, H., Denız, O., Alışık, M., & Erel, Ö. (2016) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2016.12.009 · Cited by 29
Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+
Bonnet, J.-J., Benmansour, S., Amejdki-Chab, N., & Costentin, J. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90213-5 · Cited by 29
A scientific rationale for protective therapy in Parkinson's disease
Olanow, C. W. (1993) · Journal of Neural Transmission · doi:10.1007/bf01245230 · Cited by 29
Myricetin mitigates motor disturbance and decreases neuronal ferroptosis in a rat model of Parkinson’s disease
Gu, S., Xie, Z.-G., Gu, M., Wang, C., Xu, L., Gao, C., Yuan, X., Wu, Y., Hu, Y., Cao, Y., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-62910-6 · Cited by 30
Transgenic Mice Overexpressing the Divalent Metal Transporter 1 Exhibit Iron Accumulation and Enhanced Parkin Expression in the Brain
Zhang, C., Tai, Y. K., Chai, B., Chew, K. C. M., Ang, E., Tsang, F., Tan, B. W. Q., Hong, E. T. E., Asad, A. B. A., Chuang, K., et al. (2017) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8451-0 · Cited by 28
Early events in copper-ion catalyzed oxidation of α-synuclein
Tiwari, M. K., Leinisch, F., Sahin, C., Møller, I. M., Otzen, D. E., Davies, M. J., & Bjerrum, M. J. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.04.559 · Cited by 28
Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease
Azuma, M., Hirai, T., Nakaura, T., Kitajima, M., Yamashita, S., Hashimoto, M., Yamada, K., Uetani, H., Yamashita, Y., & Wang, Y. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.116443 · Cited by 28
Predicting Motor Outcome of Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease Using Quantitative Susceptibility Mapping and Radiomics: A Pilot Study
Liu, Y., Xiao, B., Zhang, C., Li, J., Lai, Y., Shi, F., Shen, D. G., Wang, L., Sun, B., Li, Y., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.731109 · Cited by 28
Magnetic resonance imaging markers for early diagnosis of Parkinson's disease.
Marino, S., Ciurleo, R., Lorenzo, G. D., Barresi, M., Salvo, S. D., Giacoppo, S., Bramanti, A., Lanzafame, P., & Bramanti, P. (2012) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-5374.2012.08.009 · Cited by 29
1‐methyl‐4‐phenylpyridinium neurotoxicity is attenuated by adenoviral gene transfer of human Cu/Zn superoxide dismutase
Barkats, M., Horellou, P., Colin, P., Millecamps, S., Biguet, N. F., & Mallet, J. J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20696 · Cited by 28
Multimodal MRI Evaluation of the MitoPark Mouse Model of Parkinson’s Disease
Cong, L., Muir, E. R., Chen, C., Qian, Y., Liu, J., Biju, K. C., Clark, R. A., Li, S., & Duong, T. Q. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151884 · Cited by 27
Activation of ATP-sensitive potassium channels enhances DMT1-mediated iron uptake in SK-N-SH cells in vitro
Du, X., Xu, H., Shi, L., Jiang, Z., Song, N., Jiang, H. F., & Xie, J. (2016) · Scientific Reports · doi:10.1038/srep33674 · Cited by 28
Peripheral iron metabolism in patients with Parkinson's disease
Cabrera‐Valdivia, F., Jiménez‐Jiménez, F. J., Molina, J., Fernández–Calle, P., Vázquez, A., Canizares-Liebana, F., Larumbe-Lobalde, S., Ayuso‐Peralta, L., Rabasa, M., & Codoceo, R. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90246-1 · Cited by 28
Histamine Metabolites and pros-Methylimidazoleacetic Acid in Human Cerebrospinal Fluid
Prell, G. D., & Green, J. P. (1991) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7309-3_25 · Cited by 28
Coexistence of zinc and iron augmented oxidative injuries in the nigrostriatal dopaminergic system of SD rats
Lin, A. M. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00464-0 · Cited by 28
Brain Samples from Alzheimer's Patients Have Elevated Levels of Loosely Bound Iron
Kala, S. V., Hasinoff, B. B., & Richardson, J. S. (1996) · International Journal of Neuroscience · doi:10.3109/00207459608986717 · Cited by 28
Nigral damage and dopaminergic hypofunction in mesencephalon‐immunized guinea pigs
Appel, S. H., Le, W., Tajti, J., Haverkamp, L. J., & Engelhardt, J. I. (1992) · Annals of Neurology · doi:10.1002/ana.410320403 · Cited by 28
Neuroimaging in Vascular Parkinsonism
Karen, K. Y., Lin, S., & Mok, V. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-1019-7 · Cited by 27
Oral pre-treatment with epigallocatechin gallate in 6-OHDA lesioned rats produces subtle symptomatic relief but not neuroprotection
Leaver, K. R., Allbutt, H. N., Creber, N. J., Kassiou, M., & Henderson, J. M. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.08.013 · Cited by 27
Aluminium and iron in the brain—prospects for chelation
Crichton, R. R., Florence, A., & Ward, R. J. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00038-3 · Cited by 27
Docosahexaenoic Acid Ethyl Ester Enhances 6-Hydroxydopamine-Induced Neuronal Damage by Induction of Lipid Peroxidation in Mouse Striatum
Kabuto, H., Amakawa, M., Mankura, M., Yamanushi, T. T., & Mori, A. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9909-0 · Cited by 27
β‐Methylamino‐L‐Alanine (BMAA) and Amyotrophic Lateral Sclerosis–Parkinsonism Dementia of the Western Pacific
Duncan, M. W. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb24534.x · Cited by 27
In Vitro and In Vivo Protective Effects of Melatonin against Glutamate Oxidative Stress and Neurotoxicitya
Giusti, P., Lipartiti, M., Gusella, M., Floreani, M., & Manev, H. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48416.x · Cited by 27
Changes in Heat Shock Protein 70 and Ubiquitin mRNA Levels in C1300 N2A Mouse Neuroblastoma Cells Following Treatment with Iron
Uney, J. B., Anderton, B. H., & Thomas, S. M. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03198.x · Cited by 27
HFE Genotype Restricts the Response to Paraquat in a Mouse Model of Neurotoxicity
Nixon, A. M., Meadowcroft, M. D., Neely, E. B., Snyder, A. M., Purnell, C. J., Wright, J., Lamendella, R., Nandar, W., Huang, X., & Connor, J. R. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14299 · Cited by 26
Intracerebral Iron Accumulation may be Associated with Secondary Brain Injury in Patients with Poor Grade Subarachnoid Hemorrhage
Helbok, R., Rass, V., Kofler, M., Talasz, H., Schiefecker, A. J., Gaasch, M., Scherfler, C., Pfausler, B., Thomé, C., Beer, R., et al. (2021) · Neurocritical Care · doi:10.1007/s12028-021-01278-1 · Cited by 26
Effect of magnetic field and iron content on NMR proton relaxation of liver, spleen and brain tissues
Hocq, A., Luhmer, M., Saussez, S., Louryan, S., Gillis, P., & Gossuin, Y. (2014) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1610 · Cited by 26
Cell death caused by the synergistic effects of zinc and dopamine is mediated by a stress sensor gene Gadd45b – implication in the pathogenesis of Parkinson's disease
Yang, T., Wu, P., Chung, I., Jiang, J., Fann, M., & Kao, L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13728 · Cited by 26
HPLC and LC-MS studies of hydroxylation of phenylalanine as an assay for hydroxyl radicals generated from Udenfriend’s reagent
Li, M., Carlson, S., Kinzer, J. A., & Perpall, H. J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.116 · Cited by 26
Metabolic inhibition enhances selective toxicity of l-DOPA toward mesencephalic dopamine neurons in vitro
Nakao, N., Nakai, K., & Itakura, T. (1997) · Brain Research · doi:10.1016/s0006-8993(97)01116-5 · Cited by 26
Role of Protein Damage Inflicted by Dopamine Metabolites in Parkinson’s Disease: Evidence, Tools, and Outlook
Hurben, A. K., & Tretyakova, N. Y. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00193 · Cited by 25
Ferroptosis: A potential therapeutic target in autoimmune disease (Review)
Shen, L., Wang, X., Zhai, C., & Chen, Y. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12067 · Cited by 27
Resistive switching controlled by the hydration level in thin films of the biopigment eumelanin
Mauro, E. D., Carpentier, O., Sánchez, S. I. Y., Ignoumba, N. I., Myriam, L.-J., Lefebvre, J., Zhang, S., Graeff, C. F. O., Cicoira, F., & Santato, C. (2016) · Journal of Materials Chemistry C · doi:10.1039/c6tc02793h · Cited by 25
The Role of Iron in Parkinson Disease and 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Toxicity
Yantiri, F., & Andersen, J. K. (1999) · IUBMB Life · doi:10.1080/713803493 · Cited by 25
Hypoxia ameliorates neurodegeneration and movement disorder in a mouse model of Parkinson’s disease
Marutani, E., Miranda, M., Durham, T., Kim, S. H., Russell, D. L., Wiesenthal, P. P., Lichtenegger, P., Menard, M. A., Brzozowski, C. F., Li, H., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02010-4 · Cited by 28
Metals in Alzheimer’s and Parkinson’s Disease: Relevance to Dementia with Lewy Bodies
McAllum, E. J., & Finkelstein, D. I. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0809-5 · Cited by 24
Steady-State Kinetics of α-Synuclein Ferrireductase Activity Identifies the Catalytically Competent Species
McDowall, J., Ntai, I., Hake, J., Whitley, P. R., Mason, J. M., Pudney, C. R., & Brown, D. R. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00257 · Cited by 26
A Study of the Relationship Between Uric Acid and Substantia Nigra Brain Connectivity in Patients With REM Sleep Behavior Disorder and Parkinson's Disease
Ellmore, T. M., Suescun, J., Castriotta, R. J., & Schiess, M. C. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00815 · Cited by 24
Quantitative Susceptibility Mapping and Free Water Imaging of Substantia Nigra in Parkinson’s Disease
Zhang, D., Yao, J., Sun, J., Tong, Q., Zhu, S., Wang, J., Chen, L., Ma, J., He, H., & Wu, T. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223499 · Cited by 24
Element imaging in formalin fixed slices of human mesencephalon
Matusch, A., Bauer, A., & Becker, J. S. (2011) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2011.03.006 · Cited by 24
Elemental micro-imaging and quantification of human substantia nigra using synchrotron radiation based x-ray fluorescence—in relation to Parkinson’s disease
Szczerbowska‐Boruchowska, M., Krygowska‐Wajs, A., & Adamek, D. (2012) · Journal of Physics Condensed Matter · doi:10.1088/0953-8984/24/24/244104 · Cited by 24
Importance of extended spatial coverage for quantitative susceptibility mapping of iron-rich deep gray matter
Elkady, A. M., Sun, H., & Wilman, A. H. (2015) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2015.12.032 · Cited by 24
Iron uptake at the blood-brain barrier is influenced by sex and genotype
Wade, Q. W., Chiou, B., & Connor, J. R. (2019) · Advances in pharmacology · doi:10.1016/bs.apha.2019.02.005 · Cited by 24
Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases
Bacci, A., Runfola, M., Sestito, S., & Rapposelli, S. (2021) · Antioxidants · doi:10.3390/antiox10030367 · Cited by 23
Unraveling neuroprotection in Parkinson’s disease: Nrf2–Keap1 pathway’s vital role amidst pathogenic pathways
Kaur, T., Sidana, P., Kaur, N., Choubey, V., & Kaasik, A. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01549-1 · Cited by 25
Mitochondrial Dysfunction of Immortalized Human Adipose Tissue-Derived Mesenchymal Stromal Cells from Patients with Parkinson’s Disease
Moon, H. E., Yoon, S. H., Hur, Y. S., Park, H. W., Ha, J. Y., Kim, K., Shim, J. H., Yoo, S. H., Son, J. H., Paek, S. L., et al. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.4.283 · Cited by 24
Alteration in Glutathione Content and Associated Enzyme Activities in the Synaptic Terminals but not in the Non-synaptic Mitochondria from the Frontal Cortex of Parkinson’s Disease Brains
Harish, G., Mahadevan, A., Bharath, M. M. S., & Shankar, S. K. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0907-x · Cited by 23
Tert-butylhydroquinone protects PC12 cells against ferrous sulfate-induced oxidative and inflammatory injury via the Nrf2/ARE pathway
Xu, W., Li, F., Xu, Z., Sun, B., Cao, J., & Liu, Y. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.05.021 · Cited by 23
The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson’s disease and in schizophrenia
Ben‐Shachar, D. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02120-x · Cited by 23
Nano-imaging trace elements at organelle levels in substantia nigra overexpressing α-synuclein to model Parkinson’s disease
Lemelle, L., Simionovici, A., Colin, P., Knott, G. W., Bohic, S., Cloetens, P., & Schneider, B. L. (2020) · Communications Biology · doi:10.1038/s42003-020-1084-0 · Cited by 23
Delivery of Metals to Brain and the Role of the Blood-Brain Barrier
Smith, Q. R., Rabin, O., & Chikhale, E. G. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0197-2_7 · Cited by 23
Antioxidant Effects of SelegilIne in Oxidative Stress Induced by Iron Neonatal Treatment in Rats
Budni, P., de Lima, M. N. M., Polydoro, M., Moreira, J. C. F., Schröder, N., & Dal‐Pizzol, F. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9249-x · Cited by 23
Serum and urinary manganese levels in patients with Parkinson's disease
Jiménez-Jiménez, F. J., Molina, J. A., Aguilar, M. V., Arrieta, F., Jorge‐Santamaría, A., Cabrera‐Valdivia, F., Ayuso‐Peralta, L., Rabasa, M., Vázquez, A., García-Albea, E., et al. (1995) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1995.tb07014.x · Cited by 23
Distribution of iron in a single neuron of patients with Parkinson's disease
Ektessabi, A. M., Yoshida, S., & Takada, K. (1999) · X-Ray Spectrometry · doi:10.1002/(sici)1097-4539(199911/12)28:6 · Cited by 23
Pallidonigroluysian degeneration with iron deposition: a study of three autopsy cases
Kawai, J., Sasahara, M., Hazama, F., Kuno, S., Komure, O., Nomura, S., & Yamaguchi, M. (1993) · Acta Neuropathologica · doi:10.1007/bf00294300 · Cited by 23
Nigrostriatal iron accumulation in the progression of Parkinson’s disease
López‐Aguirre, M., Balzano, T., Monje, M. H. G., Esteban-García, N., Martínez‐Fernández, R., del Rey, N. L., Ciorraga, M., Sánchez‐Ferro, Á., Trigo‐Damas, I., Blesa, J., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00911-6 · Cited by 22
The interaction between metals and catecholamines: oxidative stress, DNA damage, and implications for human health
Cassera, E., Ferrari, E., Vignati, D. A. L., & Capucciati, A. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111366 · Cited by 24
A nanostructured LUS-1 based organic–inorganic hybrid optical sensor for highly selective sensing of Fe3+ in water
Karimi, M., Badiei, A., Lashgari, N., Afshani, J., & Ziarani, G. M. (2015) · Journal of Luminescence · doi:10.1016/j.jlumin.2015.07.007 · Cited by 22
Iron Concentration Does Not Differ in Blood but Tends to Decrease in Cerebrospinal Fluid in Parkinson’s Disease
Shen, X., Yang, H., Zhang, D., & Jiang, H. F. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00939 · Cited by 21
Design of functionalized fluorescent ionic liquid and its application for achieving significant improvements in Al3+ detecting
Gan, L., Guo, J., Che, S., Xiao, Q., Wang, M., You, J., & Wang, C. (2020) · Green Energy & Environment · doi:10.1016/j.gee.2020.03.006 · Cited by 21
Effect of Chronic L-Dopa or Melatonin Treatments after Dopamine Deafferentation in Rats: Dyskinesia, Motor Performance, and Cytological Analysis
Gutiérrez-Valdez, A. L., Anaya-Martı́nez, V., Ordóñez-Librado, J. L., García-Ruiz, R., Torres-Esquivel, C., Moreno-Rivera, M., Sánchez-Betancourt, J., Montiel-Flores, E., & Ávila-Costa, M. R. (2012) · ISRN Neurology · doi:10.5402/2012/360379 · Cited by 22
Application of Synchrotron Radiation in Neuromicrobiology: Role of Iron in Parkinson's Disease
Yoshida, S., Ide‐Ektessabi, A., & Fujisawa, S. (2003) · Structural Chemistry · doi:10.1023/a:1021673127598 · Cited by 22
Magnetic Resonance Imaging of Neurodegenerative Diseases
Hauser, R. A., & Olanow, C. W. (1994) · Journal of Neuroimaging · doi:10.1111/jon199443146 · Cited by 22
Environment, Genetics and Idiopathic Parkinson's Disease
Poirier, J., Kogan, S., & Gauthier, S. G. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100031334 · Cited by 22

Authors: Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D.
Affiliations: King's College London (GB)
National Hospital for Neurology and Neurosurgery (GB)
Inserm (FR)
Corresponding author: Jenner, P.
ORCID: Dexter, D. T.
Jenner, P.
Venue: Journal of Neurochemistry
Publisher: Wiley
Published: 1989-06
Volume: 52
Issue: 6
Pages: 1830-1836
ISSN: 0022-3042 (ISSN-L)
1471-4159
DOI: 10.1111/j.1471-4159.1989.tb07264.x
OpenAlex: W1985613988
Cited by: 1,149
References: 29
Citations by year: 2026: 18 · 2025: 26 · 2024: 31 · 2023: 32 · 2022: 46 · 2021: 42 · 2020: 35 · 2019: 33 · 2018: 35 · 2017: 41 · 2016: 45 · 2015: 21 · 2014: 37 · 2013: 45 · 2012: 41
FWCI: 24.67
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 6335 d)
Locations: Journal of Neurochemistry (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
Keywords: Parkinson's disease, substantia nigra, iron, copper, zinc, manganese, lead, globus pallidus, caudate nucleus, putamen, oxidative stress, neurodegeneration
MeSH terms: Aged, Aged, 80 and over, Brain, Female, Humans, Ions, Iron, Male, Metals, Parkinson Disease, Substantia Nigra, Tissue Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks